FDA DEVICE FACTS
Double Medical Femoral Nail System
Double Medical Technology, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Complete original indications for use
Double Medical Femoral Nail System is intended for femoral fracture fixation and promoting femoral fracture healing. Indications for use of the Proximal Femoral Nail, Anti-rotation, short; and Anatomical Proximal Femoral Nail (APFN ), short (Length 170 mm - 240 mm) include: – Pertrochanteric fractures (31-A1 and 31-A2); – Intertrochanteric fractures (31-A3); – High subtrochanteric fractures (32-A1). Indications for use of the Proximal Femoral Nail, Anti-rotation, long (Length 300 mm - 420 mm), Anatomical Proximal Femoral Nail (APFN ), long (Length 300 mm - 480 mm) include: – Low and extended subtrochanteric fractures; – Ipsilateral trochanteric fractures; – Combination fractures (in the proximal femur); – Pathological fractures. Indications for use of the Universal Femoral Nail, Cannulated (UFN I) include: – Femoral shaft fractures. Indications for use of the Universal Femoral Nail II, Cannulated (UFN II) include: – Standard Locking UFN II: femoral shaft fractures; – Reconstruction Locking UFN II : femoral shaft combined with femoral neck fractures, subtrochanteric fractures.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。